Compounds > thiophenes
Page last updated: 2024-08-18

thiophenes and dasatinib

thiophenes has been researched along with dasatinib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Humphreys, WG; Josephs, JL; Li, W; Skiles, GL1
Jung, SH; Ryu, WS; Sun, X; Yang, BS1
Bertoni, F; Carrassa, L; Chilà, R; Damia, G; Kwee, I; Lupi, M; Restelli, V; Rinaldi, A1

Other Studies

3 other study(ies) available for thiophenes and dasatinib

ArticleYear
Metabolite generation via microbial biotransformations with Actinomycetes: rapid screening for active strains and biosynthesis of important human metabolites of two development-stage compounds, 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:4

    Topics: Actinobacteria; Animals; Biotransformation; Dasatinib; Drugs, Investigational; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Pyrimidines; Rats; Spiro Compounds; Swine; Thiazoles; Thiophenes

2008
Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice.
    The British journal of dermatology, 2013, Volume: 168, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminopyridines; Animals; Anti-Inflammatory Agents; Atrophy; Dasatinib; Dermatitis, Allergic Contact; Drug Evaluation; Female; Mice; Mice, Hairless; Mice, Inbred BALB C; Oxazolone; Protein Kinase Inhibitors; Pyrimidines; Skin; Thiazoles; Thiophenes

2013
Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736.
    Oncotarget, 2015, Nov-10, Volume: 6, Issue:35

    Topics: Antineoplastic Agents; Benzodiazepinones; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Cyclin D1; Dasatinib; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Lymphoma, Mantle-Cell; Molecular Targeted Therapy; Nuclear Proteins; Protein Kinase Inhibitors; Protein Kinases; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Signal Transduction; src-Family Kinases; Thiophenes; Time Factors; Urea

2015